Florida to receive doses of pre-exposure antibody treatment for cancer and transplant patients
Evusheld offers about six months of protection if administered before a patient is exposed to the virus, Gov. Ron DeSantis said during a news conference.
Gov. Ron DeSantis says Florida is getting thousands of doses of an antibody treatment that protects immunosuppressed people and those allergic to the COVID-19 vaccines.
Evusheld is a new monoclonal antibody product for pre-exposure prevention of COVID-19.— Ron DeSantis (@GovRonDeSantis) December 18, 2021
It is authorized specifically for individuals who are immunocompromised or have a history of severe reactions to vaccines.
Check https://t.co/7Qq1sNv1dQ for more info. pic.twitter.com/ur0OefvmQs
The two-shot antibody treatment called Evusheld offers about six months of protection if administered before a patient is exposed to the virus.
DeSantis said Friday the state is making this treatment available within a two-hour driving distance of every resident in the state.
“And the way we tried to allocate it was just say, ‘Okay, can we get it within a two hour drive of everyone in the state of Florida?’ It’s easier to do that in some areas than others," DeSantis said. "But that’s what we’ve been able to do. So you have some folks that are maybe in more rural areas, who can’t make it next door with such a limited amount, but if you get into the car, do this, this is a pretty significant thing to do.”
Several hospitals in Central Florida will receive the treatment from the federal government including Ocala Regional Medical Center, where DeSantis made his remarks Friday.
He says those hospitals and clinics were chosen based on one characteristic: they’re already administering monoclonal antibodies.
“So initially we have a very limited allocation. It’s about 3,100 doses and this initial allocation is going to go to hospitals and clinics that are already administering monoclonal antibody treatment to patients including right here in Ocala.”
The treatment received an emergency use authorization from the FDA on Wednesday.
Copyright 2021 WMFE. To see more, visit WMFE.